Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
NurExone Biologic: Erfahren Sie mehr über den Biotech-Gral!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AUD3 | ISIN: GB00BD3VFW73 | Ticker-Symbol: 2CV
Frankfurt
09.05.24
09:20 Uhr
3,040 Euro
0,000
0,00 %
1-Jahres-Chart
CONVATEC GROUP PLC Chart 1 Jahr
5-Tage-Chart
CONVATEC GROUP PLC 5-Tage-Chart
RealtimeGeldBriefZeit
3,0203,12009.05.
3,0603,10009.05.
Dow Jones News
686 Leser
Artikel bewerten:
(2)

Convatec Group PLC: Total Voting Rights

DJ Convatec Group PLC: Total Voting Rights

Convatec Group PLC (CTEC) 
Convatec Group PLC: Total Voting Rights 
29-Sep-2023 / 19:33 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
29 September 2023 
Convatec Group Plc 
("Convatec" or "the Company") 
Total Voting Rights 
The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency 
Rule 5.6.1. As at 29 September 2023, the Company's issued capital with voting rights consisted of 2,049,789,559 
ordinary shares of 10p each ("Shares"). The Company does not hold any Shares in Treasury at the date of this 
disclosure. 
The above figure (2,049,789,559) can be used by shareholders as the denominator for the calculations by which to 
determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK 
Financial Conduct Authority's Disclosure and Transparency Rules. 
 
Enquiries 
 
Grace McCalla, Senior Assistant Company Secretary                      +44(0)7575353388 
 
Cosec@convatec.com 
 
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92 
 
About Convatec 
 
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and 
technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced 
wound care, ostomy care, continence care and infusion care. With around 10,000 colleagues, we provide our products and 
services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, 
from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group 
revenues in 2022 were over USD2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more 
about Convatec, please visit www.convatecgroup.com. 
 
=---------------------------------------------------------------------------------------------------------------------- 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
ISIN:     GB00BD3VFW73 
Category Code: TVR 
TIDM:     CTEC 
LEI Code:   213800LS272L4FIDOH92 
Sequence No.: 275017 
EQS News ID:  1738565 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1738565&application_name=news

(END) Dow Jones Newswires

September 29, 2023 14:33 ET (18:33 GMT)

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2023 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.